Document Type : Original Research


1 Vali-e Asr Hospital, Zanjan, Iran

2 Department of Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran



Breast cancer is one of the common malignant tumors worldwide accounting for 15% of all cancer-related deaths. Since a timely diagnosis of BC is essential for optimal treatment and also increasing the survival rate of patients. Today, various financial support is applied to find the best biomarkers. Considering the financial issue, in-silico analysis is the best approach. LRP family proteins are important components of cell-surface receptors that involved in numerous biological activities. One of the most pivotal role LRPs is Wnt signaling pathway. Expression of LRP is related with BC malignancy. In this study, we first investigated expression of LRPs in BC tissues in comparison with normal tissues. Relation of LRP expression with RFS and OS. Then, we investigated the association of LRPs expression and immune infiltrating abundance.


Main Subjects

  1. Bell DW. Our changing view of the genomic landscape of cancer. J Pathol. 2010;220(2):231-43. [DOI:10.1002/path.2645] [PMID]
  2. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318(5853):1108-13. [DOI:10.1126/science.1145720] [PMID]
  3. Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA: Cancer J Clin. 2021;71(6):466-87. [DOI:10.3322/caac.21695] [PMID]
  4. Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer. 2018;9(3):243-51.
  5. Campion O, Al Khalifa T, Langlois B, Thevenard-Devy J, Salesse S, Savary K, et al. Contribution of the low-density lipoprotein receptor family to breast cancer progression. Front Oncol. 2020;10:882. [DOI:10.3389/fonc.2020.00882] [PMID]
  6. Campion O, Thevenard Devy J, Billottet C, Schneider C, Etique N, Dupuy J-W, et al. LRP-1 matricellular receptor involvement in triple negative breast cancer tumor angiogenesis. Biomedicines. 2021;9(10):1430. [DOI:10.3390/biomedicines9101430] [PMID]
  7. Mohamadian M, Parsamanesh N, Chiti H, Sathyapalan T, Sahebkar A. Protective effects of curcumin on ischemia/reperfusion injury. Phytother Res. 2022;36(12):4299-324. [DOI:10.1002/ptr.7620] [PMID]
  8. Saravani S, Parsamanesh N, Miri-Moghaddam E. Role of EGFR gene polymorphisms in oral squamous cell carcinoma patients of Southeast Iran: A case-control study. Casp J Intern Med. 2020;11(4):391.
  9. Parsamanesh N, Moossavi M, Tavakkoli T, Javdani H, Fakharian T, Moossavi SZ, et al. Positive correlation between vitamin D receptor gene TaqI variant and gastric cancer predisposition in a sample of Iranian population. J Cell Physiol. 2019;234(9):15044-7. [DOI:10.1002/jcp.28145] [PMID]
  10. Roshan-Milani S, Seyyedabadi B, Saboory E, Parsamanesh N, Mehranfard N. Prenatal stress and increased susceptibility to anxiety-like behaviors: role of neuroinflammation and balance between GABAergic and glutamatergic transmission. Stress. 2021;24(5):481-95. [DOI:10.1080/10253890.2021.1942828] [PMID]
  11. Roslan Z, Muhamad M, Selvaratnam L, Ab-Rahim S. The roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review. J Oncol. 2019;2019. [DOI:10.1155/2019/4536302] [PMID]
  12. Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725-31. [DOI:10.1007/s10549-009-0674-9] [PMID]
  13. Jézéquel P, Frénel J-S, Campion L, Guérin-Charbonnel C, Gouraud W, Ricolleau G, et al. bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses. Database. 2013;2013. [DOI:10.1093/database/bas060] [PMID]
  14. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102. [DOI:10.1093/nar/gkx247] [PMID]
  15. Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649-58. [DOI:10.1016/j.neo.2017.05.002] [PMID]
  16. Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-D13. [DOI:10.1093/nar/gky1131] [PMID]
  17. Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47(D1):D607-D13. [DOI:10.1093/nar/gky1131] [PMID]
  18. Dorner TE, Tröstl A, Womastek I, Groman E. Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program. Nicotine Tobacco Res. 2011;13(11):1068-75. [DOI:10.1093/ntr/ntr179] [PMID]
  19. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1-10. [DOI:10.1038/s41467-019-09234-6] [PMID]
  20. Asplund A, Edqvist PHD, Schwenk JM, Pontén F. Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research. Proteomics. 2012;12(13):2067-77. [DOI:10.1002/pmic.201100504] [PMID]
  21. Emonard H, Théret L, Bennasroune A, Dedieu S. Regulation of LRP-1 expression: make the point. Pathol Biol. 2014;62(2):84-90. [DOI:10.1016/j.patbio.2014.02.002] [PMID]
  22. Rodrigues dos Santos C, Domingues G, Matias I, Matos J, Fonseca I, de Almeida JM, et al. LDL-cholesterol signaling induces breast cancer proliferation and invasion. Lipids Health Dis. 2014;13(1):1-9. [DOI:10.1186/1476-511X-13-16] [PMID]
  23. Cabezas F, Farfán P, Marzolo M-P. Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1). Plos One. 2019;14(5):e0213127. [DOI:10.1371/journal.pone.0213127] [PMID]
  24. Ishii H, Kim D-H, Fujita T, Endo Y, Saeki S, Yamamoto TT. cDNA cloning of a new low-density lipoprotein receptor-related protein and mapping of its gene (LRP3) to chromosome bands 19q12-q13. 2. Genomics. 1998;51(1):132-5. [DOI:10.1006/geno.1998.5339] [PMID]
  25. DePew AT, Mosca TJ. Conservation and innovation: versatile roles for LRP4 in nervous system development. J Dev Biol. 2021;9(1):9. [DOI:10.3390/jdb9010009] [PMID]
  26. O'Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733-D45. [DOI:10.1093/nar/gkv1189] [PMID]
  27. Wan D, Gong Y, Qin W, Zhang P, Li J, Wei L, et al. Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc Natl Acad Sci U S A. 2004;101(44):15724-9. [DOI:10.1073/pnas.0404089101] [PMID]
  28. Grasse S, Lienhard M, Frese S, Kerick M, Steinbach A, Grimm C, et al. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance. Genome Med. 2018;10(1):55. [DOI:10.1186/s13073-018-0562-1] [PMID]
  29. Qing J, Wei D, Maher VM, McCormick JJ. Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines. Oncogene. 1999;18(2):335-42. [DOI:10.1038/sj.onc.1202290] [PMID]
  30. Taheri M, Motalebzadeh J, Mahjoubi F. Expression of LRP Gene in Breast Cancer Patients Correlated with MRP1 as Two Independent Predictive Biomarkers in Breast Cancer. Asian Pac J Cancer Prev. 2018;19(11):3111-5. [DOI:10.31557/APJCP.2018.19.11.3111] [PMID]